Reuters logo
2 个月前
BRIEF-FDA grants Ignyta breakthrough therapy designation for entrectinib
2017年5月15日 / 上午11点25分 / 2 个月前

BRIEF-FDA grants Ignyta breakthrough therapy designation for entrectinib

1 分钟阅读

May 15 (Reuters) - Ignyta Inc

* Ignyta granted breakthrough therapy designation for entrectinib by U.S. Food and Drug Administration Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below